Biognosys raised €4.4M in a Series C round in Jul 2017. The company is based in Switzerland. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
This is the company's only recorded round.
